Oncocyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Oncocyte and buy or sell other stocks, ETFs, and their options commission-free!

About OCX

Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. 

CEO
Joshua Riggs, MBA
CEOJoshua Riggs, MBA
Employees
58
Employees58
Headquarters
Nashville, Tennessee
HeadquartersNashville, Tennessee
Founded
2009
Founded2009
Employees
58
Employees58

OCX Key Statistics

Market cap
93.95M
Market cap93.95M
Price-Earnings ratio
-3.20
Price-Earnings ratio-3.20
Dividend yield
Dividend yield
Average volume
198.00K
Average volume198.00K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$8.51
52 Week high$8.51
52 Week low
$2.33
52 Week low$2.33

Stock Snapshot

As of today, Oncocyte(OCX) shares are valued at $2.91. The company's market cap stands at 93.95M, with a P/E ratio of -3.20.

Oncocyte(OCX) stock opened on 2026-07-25 at —. The price climbed to — and dipped to —.

The Oncocyte(OCX)'s current trading volume is 0, compared to an average daily volume of 198K.

In the last year, Oncocyte(OCX) shares hit a 52-week high of $8.51 and a 52-week low of $2.33.

In the last year, Oncocyte(OCX) shares hit a 52-week high of $8.51 and a 52-week low of $2.33.

People also own

Based on the portfolios of people who own OCX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.